These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1857444)

  • 1. [No increase in the incidence of breast carcinoma with subcutaneous administration of estradiol].
    Ned Tijdschr Geneeskd; 1991 Jun; 135(25):1145-6. PubMed ID: 1857444
    [No Abstract]   [Full Text] [Related]  

  • 2. [No increase in the incidence of breast carcinoma with subcutaneous administration of estradiol].
    Davelaar EM; Gerretsen G; Relyveld J
    Ned Tijdschr Geneeskd; 1991 Apr; 135(14):613-5. PubMed ID: 2030789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Estrace (micronized 17 beta-estradiol).
    Martin PL
    Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):39-44. PubMed ID: 2906339
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What effects estrogen and progesterone have in the development of breast cancer, thrombosis and the function of the vocal cords].
    Pulkkinen M
    Duodecim; 1996; 112(4):282-3. PubMed ID: 10590642
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increased risk of breast cancer following estrogen substitution after all? Hormone substitution in peri- and postmenopause--Swedish studies].
    von Werder K
    Fortschr Med; 1989 Nov; 107(34):723-4. PubMed ID: 2606417
    [No Abstract]   [Full Text] [Related]  

  • 11. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 12. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.
    Cauley JA; Song J; Dowsett SA; Mershon JL; Cummings SR
    Breast Cancer Res Treat; 2007 Apr; 102(2):181-8. PubMed ID: 17028986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
    Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bilateral breast cancer as a complication of a prostatic cancer, treated with hormones].
    Lindberg J; Tallgren U
    Lakartidningen; 1969 Sep; 66(37):3674-8. PubMed ID: 5378939
    [No Abstract]   [Full Text] [Related]  

  • 16. Feedlot performance of steers treated concurrently with ceftiofur crystalline-free acid subcutaneously in the posterior aspect of the ear and a growth-promoting implant.
    Hibbard B; Robb EJ; Apley MD; Chester ST; Dame KJ
    Vet Ther; 2002; 3(3):252-61. PubMed ID: 12447832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms].
    van Leusden HA
    Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2301-4. PubMed ID: 3696269
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholestatic jaundice induced by spontaneous disruption of an oestrogen implant.
    Bowling TE; al-Adnani M; Silk DB
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):85-6. PubMed ID: 7866818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.